Clinical Trials in Tennessee

Showing 9941-9960 of 15,329 trials

Use of 2% Chlorhexidine Cloths Reduce Surgical Site Infections

NCT02385708

Use of 2% chlorhexidine gluconate cloths pre-operatively and daily post-operatively jaw line to toes will decrease surgical site infections (SSI) by 30% when compared to patients who receive routine standard of care (use of chlorhexidine cloths night before surgery and morning of surgery).

Surgical Site Infection

Vanderbilt University163 participantsStarted Aug 2015

Nashville, Tennessee, United States

TERMINATEDPhase 129 miles

Rituximab, Lenalidomide, and Nivolumab in Treating Participants With Relapsed or Refractory Non-Germinal Center Type Diffuse Large B Cell Lymphoma or Primary Central Nervous System Lymphoma

NCT03558750

This phase I/II trial studies the side effects and best dose of lenalidomide when given in combination with rituximab and nivolumab and how well they work in treating participants with non-germinal center type diffuse large B cell lymphoma or primary central nervous system lymphoma that has come back or isn't responding to treatment. Monoclonal antibodies, such as rituximab and nivolumab, may interfere with ability of cancer cells to grow and spread. Drugs used in chemotherapy, such as lenalidomide, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving rituximab, lenalidomide, and nivolumab may work better in treating participants with diffuse large B cell lymphoma.

Recurrent Central Nervous System LymphomaRecurrent Diffuse Large B-Cell LymphomaRefractory Central Nervous System Lymphoma+1 more

Vanderbilt-Ingram Cancer Center6 participantsStarted Jun 2018

Nashville, Tennessee, United States

Use of 2% Chlorhexidine Cloths Reduce Surgical Site Infections

Rituximab, Lenalidomide, and Nivolumab in Treating Participants With Relapsed or Refractory Non-Germinal Center Type Diffuse Large B Cell Lymphoma or Primary Central Nervous System Lymphoma

Find Trials by Condition in Tennessee

Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy

Resveratrol in Metabolic Syndrome: Effect on Platelet Hyper-reactivity and HDL Lipid Peroxidation

Validation of an Assay to Measure Cyclooxygenase-1 Activity

A Study of the Efficacy and Safety of a 3-month Treatment Course of Ulipristal Acetate for the Treatment of Abnormal Uterine Bleeding Associated With Leiomyomas

MEmbranous Nephropathy Trial Of Rituximab

Safety and Efficacy Evaluation of DOTAREM® in MRI of Central Nervous System (CNS) Lesions

Study Evaluating Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: The HEADWAY-DLB Study

A Study of Nivolumab Safety and Pharmacokinetics in Patients With Severe Sepsis or Septic Shock.

Safety and Efficacy of Entospletinib (ENTO [GS-9973]) Combined With Vincristine (VCR) in Adult Participants With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (NHL)

Sorafenib for Hepatopulmonary Syndrome

Assessment of nanOss Bioactive 3D in the Posterolateral Spine

Ultherapy® for Treating the Face and Neck Using Standard Versus Simulines Transducers

The Respiratory Protection Effectiveness Clinical Trial

Study of Teriparatide (FORTEO) to Treat Adults With Osteogenesis Imperfecta

A Randomized Trial of Effects of Parent Mentors on Insuring Minority Children

Safety and Efficacy Study of Dexamethasone Versus Ranibizumab in Patients With Diabetic Macular Edema

A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Retinal Vein Occlusion

A Study Evaluating the Efficacy and Safety of BOTOX® or Solifenacin in Patients With Overactive Bladder and Urinary Incontinence